查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1409718

2024 年產前 DNA定序全球市場報告

Prenatal DNA Sequencing Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，產前DNA定序的市場規模迅速擴大。將從2023年的22.3億美元擴大到2024年的25.6億美元，複合年成長率為14.7%。過去一段時間的成長是由於患者偏好的變化、醫學領域的進步和研究、非侵入性檢測的增加、產婦年齡的增加以及產前 DNA定序的準確性和可靠性的提高。

產前 DNA定序市場規模預計在未來幾年將快速成長。 2028年，將以15.5%的複合年成長率成長至45.6億美元。預測期內的預期成長是由於消費者對早期檢測的需求、孕產婦年齡的增加和相關懷孕風險、公共衛生舉措、監管機構的支持和對指南的遵守以及資料分析的進步。預測期內預期的顯著趨勢包括加強研究和開發、考慮倫理和法律規範、增強資料解釋工具、整合精準醫療以及增加產前遺傳諮詢。

癌症發生率的預期上升將推動產前 DNA定序市場的成長。以不受控制的細胞生長和擴散為特徵的癌症促使使用產前 DNA定序來檢測胎兒非整倍體並識別胎兒癌症。這種定序方法揭示了影響人類對癌症易感性的遺傳或種系 DNA 變化。例如，根據美國癌症協會2023年1月的資料，癌症患者人數從2021年的1,898,160人增加到2023年的1,958,310人，增加了3.16%。因此，癌症盛行率是推動產前 DNA定序市場的驅動力。

出生率的提高預計將促進產前 DNA定序市場的成長。出生率衡量的是特定人群和時間段內每 1,000 人的出生人數，這與使用產前 DNA定序來識別胎兒遺傳異常的情況一致。這有助於做出明智的生殖決定並在分娩期間實施選擇性干預措施。 2022年5月，美國疾病管制與預防中心（CDC）報告稱，美國出生人數較2020年增加1%，2021年出生總合達到3,659,289人。 2021年整體出生率也成長了1%，每1000名15至44歲女性生育56.6個孩子。因此，出生率的上升是產前 DNA定序市場的推動要素。

2023年產前DNA定序市場最大的地區是北美。產前 DNA定序市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

目錄

第1章執行摘要

第2章 產前DNA定序市場特點

第3章產前DNA定序市場趨勢與策略

第4章產前DNA定序市場-宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章 全球產前DNA定序市場規模及成長

  • 全球市場促進因素與抑制因素
    • 市場促進因素
    • 市場抑制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長，2023-2028、2033

第6章產前DNA定序市場區隔

  • 全球產前 DNA定序市場，按類型細分、實際和預測，2018-2023、2023-2028、2033
  • 遺傳疾病
  • 非遺傳性疾病
  • 全球產前 DNA定序市場，按應用、效能和預測細分，2018-2023、2023-2028、2033
  • 血友病
  • 唐氏症
  • 囊腫纖維化
  • 自閉症
  • 迪喬治症候群
  • 愛滋病（後天免疫力缺乏症候群）
  • 癌症
  • 其他用途
  • 全球產前 DNA定序市場，依最終用戶細分，實際與預測，2018-2023、2023-2028、2033
  • 學術研究
  • 臨床研究
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他最終用戶

第7章產前 DNA定序市場區域與國家分析

  • 全球產前 DNA定序市場，按地區、實際和預測，2018-2023、2023-2028、2033
  • 全球產前 DNA定序市場（按國家/地區、實際情況和預測）2018-2023 年、2023-2028 年、2033 年

第8章亞太產前DNA定序市場

第9章中國產前DNA定序市場

第10章 印度產前DNA定序市場

第11章 日本產前DNA定序市場

第12章 澳洲產前DNA定序市場

第13章 印尼產前DNA定序市場

第14章 韓國產前DNA定序市場

第15章 西歐產前DNA定序市場

第16章英國產前DNA定序市場

第17章 德國產前DNA定序市場

第18章 法國產前DNA定序市場

第19章 義大利產前DNA定序市場

第20章 西班牙產前DNA定序市場

第21章 東歐產前DNA定序市場

第22章 俄羅斯產前DNA定序市場

第23章 北美產前DNA定序市場

第24章美國產前DNA定序市場

第25章 加拿大產前DNA定序市場

第26章 南美洲產前DNA定序市場

第27章 巴西產前DNA定序市場

第28章 中東產前DNA定序市場

第29章 非洲產前DNA定序市場

第30章產前DNA定序市場競爭形勢及公司概況

  • 產前DNA定序市場競爭形勢
  • 產前 DNA定序市場公司概況
    • Agilent Technologies Inc.
    • BGI Group
    • F. Hoffmann-La Roche Ltd
    • Illumina Inc.
    • Laboratory Corporation of America Holdings

第31章 全球產前DNA定序市場競爭基準化分析

第32章全球產前DNA定序市場競爭儀表板

第33章 產前DNA定序市場重大併購

第34章產前DNA定序市場未來展望及可能性分析

第35章附錄

簡介目錄
Product Code: r11256

“Prenatal DNA Sequencing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal dank sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal dank sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The prenatal dank sequencing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Genetic Diseases; Nonhereditary Diseases
  • 2) By Application: Hemophilia; Down Syndrome; Cystic Fibrosis; Autism; DiGeorge Syndrome; AIDS (Acquired Immunodeficiency Syndrome); Cancer; Other Applications
  • 3) By End User: Academic Research; Clinical Research; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
  • Companies Mentioned: Agilent Technologies Inc.; BGI Group; F. Hoffmann-La Roche Ltd; Illumina Inc.; Laboratory Corporation of America Holdings
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Prenatal DNA sequencing is a method employed to sequence the DNA of an unborn baby, utilizing a blood sample from the mother to unveil the complete genetic code of the fetus. This technique is instrumental in detecting fetal disorders or diseases.

The primary types of prenatal DNA sequencing encompass genetic diseases and nonhereditary diseases. Genetic diseases refer to disorders or diseases caused by mutations in one or more genes. DNA sequencing plays a crucial role in determining whether a gene carries a mutation leading to a specific disorder. Applications of prenatal DNA sequencing include conditions such as hemophilia, Down syndrome, cystic fibrosis, autism, DiGeorge syndrome, AIDS, cancer, and others. Various users, including academic research, clinical research, hospitals and clinics, as well as pharmaceutical and biotechnology companies, employ this technology.

The prenatal DNA sequencing market research report is one of a series of new reports from The Business Research Company that provides prenatal DNA sequencing market statistics, including the prenatal DNA sequencing industry global market size, regional shares, competitors with a prenatal DNA sequencing market share, detailed prenatal DNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal DNA sequencing industry. This prenatal DNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal dna sequencing market size has grown rapidly in recent years. It will grow from $2.23 billion in 2023 to $2.56 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth observed in the historical period can be attributed to changes in patient preferences, advancements and research in the medical field, increased adoption of non-invasive testing, a rise in maternal age, and enhancements in the accuracy and reliability of prenatal DNA sequencing.

The prenatal dna sequencing market size is expected to see rapid growth in the next few years. It will grow to $4.56 billion in 2028 at a compound annual growth rate (CAGR) of 15.5%. The anticipated growth in the forecast period can be attributed to consumer demand for early detection, an increase in maternal age and associated pregnancy risks, public health initiatives, support from regulatory bodies and adherence to guidelines, and advancements in data analysis. Noteworthy trends expected in the forecast period include intensified research and development efforts, considerations related to ethics and regulatory frameworks, enhancements in data interpretation tools, integration of precision medicine, and the promotion of prenatal genetic counseling.

The anticipated rise in cancer prevalence is set to drive the growth of the prenatal DNA sequencing market. Cancer, characterized by uncontrolled cell growth and spread, prompts the use of prenatal DNA sequencing to detect fetal aneuploidy and identify cancer in the fetus. This sequencing method unveils inherited or germline DNA changes influencing a person's cancer susceptibility. For example, data from the American Cancer Society in January 2023 showed an increase in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth rate of 3.16%. Consequently, the prevalence of cancer acts as a driving force for the prenatal DNA sequencing market.

The expected increase in the birth rate is poised to contribute to the growth of the prenatal DNA sequencing market. Birth rate, indicating the number of live births per 1,000 people in a specified population and time period, aligns with the use of prenatal DNA sequencing to identify genetic abnormalities in unborn fetuses. This aids in making informed reproductive decisions and implementing selective interventions during birth. In May 2022, the Centers for Disease Control and Prevention (CDC) reported a 1% rise in U.S. births compared to 2020, reaching a total of 3,659,289 births in 2021. The overall fertility rate for 2021 also increased by 1%, standing at 56.6 births per 1,000 women aged 15-44. Thus, the higher birth rate acts as a driving factor for the prenatal DNA sequencing market.

Product innovation is a prominent trend in the prenatal DNA sequencing market, with major companies concentrating on developing innovative solutions to enhance their market standing. Juno Diagnostics, Inc., a U.S.-based health technology company, introduced the noninvasive prenatal screening test 'Hazel' in November 2022. Designed with no risk of miscarriage, the test can be performed as early as 9 weeks into pregnancy using a small blood sample. It screens for common genetic conditions such as Down syndrome, Edwards syndrome, and Patau syndrome.

Major companies in the prenatal DNA sequencing market are actively developing compliance solutions, such as CE-IVD compliance solutions, to offer a next-generation sequencing approach to noninvasive prenatal testing (NIPT). Illumina, a U.S.-based life science tools developer, partnered with Next Generation Genomic in June 2021 to launch VeriSeq NIPT Solution v2 in Thailand. This CE-IVD next-generation sequencing-based approach expands prenatal screening beyond common aneuploidies to rare autosomal aneuploidies, sex chromosome aneuploidies, and large partial duplications and deletions.

In November 2022, Myriad Genetics, Inc., a U.S.-based provider of genetic testing and precision medicine, acquired Gateway Genomics, LLC, a personal genomics and prenatal DNA company. The undisclosed acquisition is expected to enhance Myriad's women's health product portfolio and provide access to personalized genetic tests, strengthening its position in the market.

Major companies operating in the prenatal dna sequencing market report are Agilent Technologies Inc., BGI Group, F. Hoffmann-La Roche Ltd, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Genomic Health Inc., Myriad Genetics Inc., Invitae Corporation, PerkinElmer Inc., Macrogen Inc., Pacific Biosciences of California Inc., Genewiz LLC, 10x Genomics Inc., Oxford Nanopore Technologies Limited, Thermo Fisher Scientific Inc., Berry Genomics Co. Ltd., Centrillion Technology Holdings Corp., Cynvenio Biosystems Inc., Eurofins LifeCodexx AG, Fluidigm Corp., GATC Biotech AG, GeneDx Inc., Genoma SA, Good Start Genetics Inc., Helix OpCo LLC, Igenomix S.L., Integrated DNA Technologies Inc., KellBenx Inc., LifeCodexx AG .

North America was the largest region in the prenatal DNA sequencing market in 2023. The regions covered in the prenatal dna sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal dna sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prenatal DNA sequencing market includes revenues earned by entities by provide services such as prenatal next-generation sequencing, whole genome sequencing, DNA extraction, DNA fragmentation, and data collection and sequence analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Prenatal DNA Sequencing Market Characteristics

3. Prenatal DNA Sequencing Market Trends And Strategies

4. Prenatal DNA Sequencing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Prenatal DNA Sequencing Market Size and Growth

  • 5.1. Global Prenatal DNA Sequencing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Prenatal DNA Sequencing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Prenatal DNA Sequencing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Prenatal DNA Sequencing Market Segmentation

  • 6.1. Global Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Genetic Diseases
  • Nonhereditary Diseases
  • 6.2. Global Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hemophilia
  • Down Syndrome
  • Cystic Fibrosis
  • Autism
  • DiGeorgre Syndrome
  • AIDS (Acquired Immunodeficiency Syndrome)
  • Cancer
  • Other Applications
  • 6.3. Global Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic Research
  • Clinical Research
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Other End Users

7. Prenatal DNA Sequencing Market Regional And Country Analysis

  • 7.1. Global Prenatal DNA Sequencing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Prenatal DNA Sequencing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Prenatal DNA Sequencing Market

  • 8.1. Asia-Pacific Prenatal DNA Sequencing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Prenatal DNA Sequencing Market

  • 9.1. China Prenatal DNA Sequencing Market Overview
  • 9.2. China Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Prenatal DNA Sequencing Market

  • 10.1. India Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Prenatal DNA Sequencing Market

  • 11.1. Japan Prenatal DNA Sequencing Market Overview
  • 11.2. Japan Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Prenatal DNA Sequencing Market

  • 12.1. Australia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Prenatal DNA Sequencing Market

  • 13.1. Indonesia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Prenatal DNA Sequencing Market

  • 14.1. South Korea Prenatal DNA Sequencing Market Overview
  • 14.2. South Korea Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Prenatal DNA Sequencing Market

  • 15.1. Western Europe Prenatal DNA Sequencing Market Overview
  • 15.2. Western Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Prenatal DNA Sequencing Market

  • 16.1. UK Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Prenatal DNA Sequencing Market

  • 17.1. Germany Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Prenatal DNA Sequencing Market

  • 18.1. France Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Prenatal DNA Sequencing Market

  • 19.1. Italy Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Prenatal DNA Sequencing Market

  • 20.1. Spain Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Prenatal DNA Sequencing Market

  • 21.1. Eastern Europe Prenatal DNA Sequencing Market Overview
  • 21.2. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Prenatal DNA Sequencing Market

  • 22.1. Russia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Prenatal DNA Sequencing Market

  • 23.1. North America Prenatal DNA Sequencing Market Overview
  • 23.2. North America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Prenatal DNA Sequencing Market

  • 24.1. USA Prenatal DNA Sequencing Market Overview
  • 24.2. USA Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Prenatal DNA Sequencing Market

  • 25.1. Canada Prenatal DNA Sequencing Market Overview
  • 25.2. Canada Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Prenatal DNA Sequencing Market

  • 26.1. South America Prenatal DNA Sequencing Market Overview
  • 26.2. South America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Prenatal DNA Sequencing Market

  • 27.1. Brazil Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Prenatal DNA Sequencing Market

  • 28.1. Middle East Prenatal DNA Sequencing Market Overview
  • 28.2. Middle East Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Prenatal DNA Sequencing Market

  • 29.1. Africa Prenatal DNA Sequencing Market Overview
  • 29.2. Africa Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Prenatal DNA Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Prenatal DNA Sequencing Market Competitive Landscape
  • 30.2. Prenatal DNA Sequencing Market Company Profiles
    • 30.2.1. Agilent Technologies Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. BGI Group
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. F. Hoffmann-La Roche Ltd
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Illumina Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Laboratory Corporation of America Holdings
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Prenatal DNA Sequencing Market Competitive Benchmarking

32. Global Prenatal DNA Sequencing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Prenatal DNA Sequencing Market

34. Prenatal DNA Sequencing Market Future Outlook and Potential Analysis

  • 34.1 Prenatal DNA Sequencing Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Prenatal DNA Sequencing Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Prenatal DNA Sequencing Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer